Cardio Diagnostics Holdings Inc. (CDIO) - Rasio cepet

Cardio Diagnostics (CDIO) is led by a competent management team integrating artificial intelligence into cardiac screening while maintaining strict regulatory compliance. This chart of share price action confirms the brand's status as a pioneer in predictive protein and DNA analysis for detecting cardiac pathologies. The current indicator stands at 17.37, which is significant amid the expansion of epigenetic testing and rising demand in telemedicine.

For Cardio Diagnostics, the efficiency of express genetic test delivery depends directly on the ability to quickly cover operational obligations. This metric measures the company's ability to settle short-term debts using only cash and accounts receivable, excluding inventory. The current quick ratio of 17.37 reflects the real margin of financial strength. A high value confirms the business model's resilience to logistics costs and the issuer's solvency.